This page shows results related to Alaway and Erythema Of Eyelid from the FDA Adverse Event Reporting System (AERS). The adverse event Erythema Of Eyelid has been reported to the FDA a total of 8 times for Alaway.
Learn More About Alaway Adverse EventsThe Proportional Reporting Ratio (PRR) for Alaway and Erythema Of Eyelid is 122. The chart below compares this proportional reporting ratio of Erythema Of Eyelid for drugs used in similar therapies to Alaway. The higher the proportional reporting ratio is, the more likely a drug is associated with Erythema Of Eyelid.
| Erythema Of Eyelid | |
| Alaway | 50 |
NOTE: The PRR metric is still in Beta testing by DrugCite and is intended for use by researchers only.
Of those reporting Erythema Of Eyelid, why were they taking Alaway?
| Eye Allergy | 3 |
| Eye Irritation | 2 |
| Drug Use For Unknown Indication | 1 |
| Hypersensitivity | 1 |
| Eye Pruritus | 1 |
Which medications reported to the FDA are most commonly associated with Erythema Of Eyelid?
| Latisse | 373 |
| Xalatan | 58 |
| Restasis | 51 |
| Enbrel | 32 |
| Combigan | 28 |
| Humira | 23 |
| Lumigan | 23 |
| Lamictal | 22 |
| Aredia | 21 |
| Zometa | 20 |
| Botox Cosmetic | 16 |
 Show More |
